Mounjaro vs Ozempic UK: Which Weight Loss Injection Works Best?

Two injections. Both making headlines. Both changing lives — but they work differently and suit different people. Here is everything you need to know before you spend a penny.

If you have heard about weight loss jabs from a friend, seen them on the news, or quietly Googled them at midnight, you are not alone. Millions of UK women are asking the same question right now: is Mounjaro or Ozempic the better choice for me?

This development was announced on 1 January 2025, as both treatments entered the new year with full MHRA approval and growing NHS and private clinic availability across the UK.

Both are weekly injections. Both help with weight loss. But they are not the same drug, and the differences matter. This guide cuts through the noise so you can have a proper conversation with your doctor or clinic.

How Each Drug Actually Works

Ozempic contains a medicine called semaglutide. According to the MHRA, semaglutide works by copying a hormone called GLP-1 (a natural signal your gut sends to your brain when you have eaten enough). It tells your brain you are full. It slows down how quickly your stomach empties. And it reduces cravings.

Mounjaro contains a different medicine called tirzepatide. According to Eli Lilly, the company that makes it, tirzepatide copies two hormones at once — GLP-1 and another one called GIP. Think of it as a dual-action signal. Both hormones together appear to be more powerful for weight loss than GLP-1 alone.

In plain English: Ozempic pulls one lever. Mounjaro pulls two.

According to the landmark SURMOUNT-1 clinical trial, published in the New England Journal of Medicine, people taking tirzepatide (Mounjaro) lost an average of 22.5 percent of their body weight over 72 weeks. That is roughly 2.5 stone for someone weighing 16 stone.

According to the STEP-1 clinical trial, also published in the New England Journal of Medicine, people taking semaglutide (the active ingredient in Ozempic, also sold as Wegovy for weight loss) lost an average of 14.9 percent of their body weight. Meaningful — but lower than Mounjaro’s figures.

Which One Is Approved For Weight Loss In The UK?

This is where it gets important for UK patients specifically.

According to the MHRA, Wegovy (semaglutide 2.4mg) is the version of the Ozempic drug approved specifically for weight management in the UK. Ozempic itself is licensed for type 2 diabetes. Using Ozempic for weight loss is technically an off-label prescription — legal, but not what the licence covers.

According to the MHRA, Mounjaro (tirzepatide) received full UK approval for chronic weight management in adults in November 2023. It is the most recently approved option and the one with the strongest weight loss data.

On the NHS, access to either drug depends on where you live and whether you meet specific criteria. According to NHS England, Mounjaro is being rolled out through specialist weight management services from 2024, but availability remains limited. Most people currently access both drugs through private clinics.

Side effects for both are similar — nausea, constipation, and reduced appetite are the most common. According to the SURMOUNT-1 trial, most side effects with Mounjaro were mild to moderate and eased after the first few weeks. The same pattern appears in Ozempic/Wegovy studies.

If you want a deeper look at all the injectable options currently available in the UK, our Weight Loss Jabs Guide covers every approved treatment in one place.

What This Means For UK Patients

The honest answer is that Mounjaro currently has the strongest weight loss data of any approved drug in the UK. If weight loss is your primary goal and you have no contraindications, the clinical evidence points towards tirzepatide as the more powerful option. However, Wegovy (semaglutide) has a longer track record in real-world use and may suit patients who prefer a well-established treatment. Cost matters too — both are available privately, typically between £150 and £250 per month depending on dose and clinic. Neither should be started without proper medical screening. A reputable UK clinic will check your medical history, BMI, blood pressure, and any medications you take before prescribing. Be cautious of any service that skips this step. If you are unsure where to start, our Start Here guide will walk you through the process safely.

Frequently Asked Questions

Can I get Mounjaro or Ozempic on the NHS?

According to NHS England, Mounjaro is being introduced through specialist weight management services, but access is currently very limited and criteria are strict. Most UK patients access both drugs through private clinics at their own cost.

Which causes less nausea — Mounjaro or Ozempic?

According to the SURMOUNT-1 and STEP-1 trials, both drugs cause similar nausea rates, particularly in the first few weeks. Starting on a low dose and increasing gradually — as both prescribing guidelines recommend — significantly reduces this side effect.

Is it safe to buy Mounjaro or Ozempic online?

According to the MHRA, both drugs require a valid prescription from a registered UK prescriber. Buying from unregulated websites carries serious risks including counterfeit medicines. Always use a CQC-registered clinic or a pharmacy registered with the General Pharmaceutical Council. You can check our UK Clinic Reviews for vetted providers.

How long do you stay on these injections?

According to clinical guidelines referenced by NICE (the National Institute for Health and Care Excellence), these are long-term treatments. Weight tends to return when the medication is stopped, so most clinicians view them as ongoing rather than short-term interventions.

This article is for information purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any treatment.